0 Comments
0 Shares
7 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
mTOR Inhibitor Oncology Drug Market Advances with Targeted Cancer Therapy Innovations"Executive Summary mTOR Inhibitor Oncology Drug Market Size and Share Analysis Report CAGR Value The global mTOR inhibitor oncology drug market size was valued at USD 2.52 billion in 2025 and is expected to reach USD 5.32 billion by 2033, at a CAGR of 9.80% during the forecast period mTOR Inhibitor Oncology Drug Market report objective analysis is...0 Comments 0 Shares 115 Views 0 Reviews
-
Crizotinib Drugs Market Growing at 6.7% CAGR Through 2034According to a new report from Intel Market Research, the global Crizotinib Drugs market was valued at USD 582.4 million in 2025 and is projected to reach USD 1,043.7 million by 2034, growing at a CAGR of 6.7% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of lung cancer, increasing adoption of molecular diagnostic testing for genetic...0 Comments 0 Shares 72 Views 0 Reviews
-
Global Multi-target MET TKIs Market Growing at 7.6% CAGR Through 2034According to a new report from Intel Market Research, the global Multi-target MET TKIs market was valued at USD 1.52 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer and medullary thyroid cancer, precision oncology...0 Comments 0 Shares 119 Views 0 Reviews
-
How Are Targeted Therapies Shaping the Chordoma Treatment Market?Executive Summary Chordoma Treatment Market: Share, Size & Strategic Insights CAGR Value The global chordoma treatment market size was valued at USD 3.98 billion in 2024 and is expected to reach USD 6.64 billion by 2032, at a CAGR of 6.60% during the forecast period The key topics that have been described in this Chordoma Treatment Market report include market definition, market...0 Comments 0 Shares 168 Views 0 Reviews
-
Navigating the Future of Adult Malignant Glioma Therapeutics: Market Growth, Opportunities, and Strategic Insights 2031The Adult Malignant Glioma Therapeutics Market is advancing at a robust pace, propelled by the rising prevalence of malignant brain tumors and the continuous evolution of treatment modalities. According to insights from The Insight Partners, the The Adult Malignant Glioma Therapeutics Market size is expected to reach US$ 5.39 Billion by 2031. The market is anticipated to register a CAGR of 9.8%...0 Comments 0 Shares 146 Views 0 Reviews
-
Neurofibromatosis Drugs Market Industry Insights and ForecastNeurofibromatosis is a rare genetic disorder characterized by the growth of tumors along nerves in the skin, brain, and other parts of the body. The increasing prevalence of rare neurological disorders, advancements in targeted therapies, and rising investments in orphan drug development are driving significant growth in the neurofibromatosis drugs industry. Pharmaceutical companies are...0 Comments 0 Shares 5 Views 0 Reviews
-
Ovarian Cancer Diagnostics and Therapeutics Market Revenue Growth TrendsThe global ovarian cancer diagnostics and therapeutics market is witnessing significant growth due to the increasing prevalence of ovarian cancer, rising awareness regarding early detection, and continuous advancements in precision medicine. Healthcare providers and pharmaceutical companies are investing heavily in innovative diagnostic technologies and targeted treatment approaches to improve...0 Comments 0 Shares 8 Views 0 Reviews
-
TKIs for Breast Cancer Market Growing at 7.3% CAGR Through 2034According to a new report from Intel Market Research, the global TKIs for Breast Cancer market was valued at USD 1.82 billion in 2025 and is projected to reach USD 3.74 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2025–2034). This growth is propelled by the rising global incidence of breast cancer, growing adoption of precision oncology, and increasing regulatory...0 Comments 0 Shares 88 Views 0 Reviews